Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2025-12-24 @ 2:14 PM
NCT ID: NCT03540095
Eligibility Criteria: Inclusion Criteria: * Age between 18-85 years * no contraindications to the placement of a paravertebral catheter or erector spinae plane catheter * American Society of Anesthesiologists physical status between I-IV * no chronic opioid use * patients who are not expected to be on therapeutic anticoagulants post-procedurally * no clopidogrel in last 48 hours * no known allergies to any of the drugs/agents used study protocol * no personal or family history of malignant hyperthermia * not pregnant * not having an altered mental status (oriented to place, person, or time) * no comorbid condition(s) that in the judgment of the anesthesiologist, would preclude the patient from any aspect of the study. Comorbid conditions include bleeding disorders, thrombocytopenia, localized infection, sepsis, possibly abnormalities of the thoracic spine or paravertebral anatomy neoplastic mass occupying the paravertebral space, empyema, allergy to local anesthestic drug, increased intracranial pressure, severe uncorrected hypovolemia, fixed cardiac output states. Exclusion Criteria: * Age younger than 18 years or older than 85 years * any contraindication to the placement of a paravertebral or erector spinae catheters * American Society of Anesthesiologists physical status V or greater * chronic opioid use * coagulation abnormalities or patients who are expected to be on therapeutic anticoagulants postprocedurally * clopidogrel use within 48 hours * allergy to any of the drugs/agents used study protocol * personal or family history of malignant hyperthermia * pregnancy * having an altered mental status (not oriented to place, person, or time), (11) any comorbid condition that in the judgment of the anesthesiologist would preclude the patient from any aspect of the study * patient refusal. Comorbid conditions include bleeding disorders, thrombocytopenia, localized infection, sepsis, possibly abnormalities of the thoracic spine or paravertebral anatomy neoplastic mass occupying the paravertebral space, empyema, allergy to local anesthetic drug, increased intracranial pressure, severe uncorrected hypovolemia, fixed cardiac output states.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT03540095
Study Brief:
Protocol Section: NCT03540095